Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × relatlimab × 90 days × Clear all

Phase

Status

Recruiting 13 Completed 4 Active not recruiting 3 Not yet recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 35 Nivolumab 12 Carboplatin 11 Specimen Handling 10 venetoclax 9 atezolizumab 9 Gemcitabine 9 Biopsy 9 fludarabine 8 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 8 Radiosurgery 7 Pemetrexed 7 Paclitaxel 7 Azacitidine 7 olaparib 6 durvalumab 6 Surveys and Questionnaires 6 Radiotherapy 6 Docetaxel 6 daratumumab 5 Trastuzumab 5 Ipilimumab 5 Interviews as Topic 5 Injections 5 Fulvestrant 5 Drug Therapy 5 Cisplatin 5 tislelizumab 4 ibrutinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05002569 2026-01-08

RELATIVITY-098

Bristol-Myers Squibb

Phase 3 Terminated

1,093 enrolled 15 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡